Jean-Philippe Guégan

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 05, 2026
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Mariella Spalato Ceruso, Jean-Philippe Guégan, Aurelien Bourdon

|Dec 10, 2025
Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin.

Laure Migayron, Ribal Merhi, Chloé Avril

|Dec 04, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer.

Alban Bessede, Florent Peyraud, Benjamin Besse

|Oct 20, 2023
Antitumor Effects of PRMT5 Inhibition in Sarcomas.

Stéphanie Verbeke, Aurélien Bourdon, Jean-Philippe Guegan

|Sep 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.

Alban Bessede, Florent Peyraud, Sylvestre Le Moulec

|Jan 18, 2022
Signaling by the tyrosine kinase Yes promotes liver cancer development.

Jean-Philippe Guégan, Marjorie Lapouge, Laure Voisin

Pageof 1